Thus, it seems to be the case that different pathomechanisms besides classical intraneuronal TDP-43 pathology could lead to motor neuron loss manifesting with similar clinical phenotypes in RFC1-pathology, but obviously with a slower progression rate as compared to classical ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.